# The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial

> **NCT00375388** · PHASE3 · COMPLETED · sponsor: **Bethesda General Hospital, Hoogeveen** · enrollment: 400 (—)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Metformin on top of intensive insulin therapy

## Key facts

- **NCT ID:** NCT00375388
- **Lead sponsor:** Bethesda General Hospital, Hoogeveen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-01
- **Primary completion:** —
- **Final completion:** 2002-10
- **Target enrollment:** 400 (—)
- **Last updated:** 2006-09-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00375388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00375388, "The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00375388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*